11 Pulmonary Embolism Clinical Trials in Lexington, MA (2026)

Q: How do I join a clinical trial in Lexington?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you.

Recruiting Pulmonary Embolism Studies in Lexington

NCT04678154Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT

The proposed study is a multi-center, prospective randomized controlled trial comparing current standard of care treatment to the SEXTANT treatment protocol in patients with Type III open fractures of...

Lexington, MA1,200 participantsMajor Extremity Trauma Research Consortium

View Study Details

NCT05301140Recruiting

Vivistim Registry for Paired VNS Therapy (GRASP)

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment...

Lexington, MA1,000 participantsMicroTransponder Inc.

View Study Details

NCT06911632Recruiting

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk ...

Lexington, MA900 participantsTempus AI

View Study Details

NCT05766670Recruiting

Intramedullary Calcium Sulfate Antibiotic Depot

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients...

Lexington, MA497 participantsWake Forest University Health Sciences

View Study Details

NCT03911700Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hern...

Lexington, MA477 participantsC. R. Bard

View Study Details

NCT06339008Recruiting

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to...

Lexington, MA450 participantsEli Lilly and Company

View Study Details

NCT04244942Recruiting

CERAMENT™| Bone Void Filler Device Registry

A device registry to compile data on the performance of CERAMENT BONE VOID FILLER in normal use....

Lexington, MA300 participantsBONESUPPORT AB

View Study Details

NCT04779554Recruiting

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Peritoneal carcinomatosis from advanced gastro-intestinal malignancy has historically been associated with poor overall survival (≤ 12 months) with few treatment options. Cytoreductive surgery (CRS), ...

Lexington, MA100 participantsPrakash Pandalai

View Study Details

NCT05001880Recruiting

Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

This phase II trial compares the usual treatment alone (carboplatin, pemetrexed, and bevacizumab) to using immunotherapy (atezolizumab) plus the usual treatment in treating patients with peritoneal me...

Lexington, MA66 participantsNational Cancer Institute (NCI)

View Study Details

NCT03481283Recruiting

A Causative Role for Amylin in Diabetic Peripheral Neuropathy

Three pieces of information lead to the basis for this study: 1. Individuals with Type-2 diabetes commonly develop peripheral neuropathy. 2. Increased production of the hormone amylin occurs in indiv...

Lexington, MA40 participantsZabeen Mahuwala, MD

View Study Details

NCT03970720Recruiting

Restoration of Hypoglycemia Awareness With Metoclopramide

Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this study is to determine ...

Lexington, MA36 participantsSimon Fisher

View Study Details

About Pulmonary Embolism Clinical Trials in Lexington

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 11 pulmonary embolism clinical trials recruiting participants in Lexington, MA. These studies are seeking a combined 5,066 participants. Research is being sponsored by Major Extremity Trauma Research Consortium, MicroTransponder Inc., Tempus AI and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Lexington — FAQ

Are there pulmonary embolism clinical trials in Lexington?

Yes, there are 11 pulmonary embolism clinical trials currently recruiting in Lexington, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lexington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.

Are clinical trials in Lexington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 11 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov